Diagnostics-World
Twitter   LinkedIn Facebookinstagram RSS  
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • Post a Press Release
    • View Press Releases
    • Submit a Story
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising Opportunities
    • Lead Generation
    • Whitepapers
    • Webinars
    • Podcasts
    • Editorial Calendar
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside Ebooks
  • Events
    • Webinars
    • Industry Events
    • Dx Conferences
    • Dx World Summit
  • About
    • Editorial Profile
    • Editorial Calendar
    • Contact
  • Dx World Summit
 
  • NIH-Supported Studies Reveal Possible Long COVID Disparities

    Diagnostics World News | Two recent studies funded by NIH’s Researching COVID to Enhance Recovery (RECOVER) Initiative reveal differences in long COVID diagnostic experiences among different racial and ethnic groups. The findings provide information about variations in symptoms and access to care.

    Apr 6, 2023
  • Liquid Biopsies Could Help Speed Up Lung Cancer Clinical Trials

    Diagnostics World News | Circulating tumor DNA (ctDNA) holds potential as a biomarker in lung cancer clinical trials as an added and easier-to-monitor endpoint to survival rates for measuring treatment efficacy. This was one of the key findings of her most recent work, where ctDNA was also shown to outperform clinical responses assessed on CT scans in the prediction of survival.

    Apr 5, 2023
  • Illumina Releases International Version of Tertiary Clinical NGS Analysis Software

    Diagnostics World News | Illumina has released Connected Insights, a cloud-based software for tertiary analysis for clinical next-generation sequencing (NGS) data. The software is commercially available in a limited number of countries and in beta testing in the US.

    Apr 4, 2023
  • CLIA-Certified Personalized Blood Test for Multiple Myeloma, Wearable Sensor Detects Blood Biomarker for Heart Attacks, More

    Diagnostics World News | Personalized treatment for high-risk patients with asthma and chronic obstructive pulmonary disease to improve their health outcomes; state-of-the-art AI algorithms provide a real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients; bioelectronic sensors that will aid in cheap, accurate, and rapid pathogen detection; and more.

    Mar 30, 2023
  • Follow the Money: Bill & Melinda Gates Foundation Fund Diagnostic Breathalyzer, European Innovation Council Backs New RNA-Based Therapies and Diagnostics, More

    Diagnostics World News | Funding for targeting extracellular proteins involved in the pathogenesis of autoimmune, neurological, and other diseases, rapid screening of infectious diseases through volatile organic compounds, a proteomics AI-based platform that comprehensively maps the course of a disease to predict which patients will respond to a given drug, and more.

    Mar 28, 2023
  • «
  • 61
  • 62
  • 63
  • 64
  • 65 (current)
  • 66
  • 67
  • 68
  • 69
  • 70
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Twitter Icon LinkedIn Icon Facebook Icon

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy